Hakkımda

İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, 2003-2009

Bakırköy Kadın Doğum ve Çocuk Hastalıkları Hastanesi, 2009-2011

Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi, 2012-2014

Şanlıurfa Çocuk Hastanesi, Çocuk Sağlığı ve Hastalıkları Uzmanı, 2014-2015

Karadeniz Teknik Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları-Çocuk Romatoloji Kliniği, 2015-2018

Diyarbakır Çocuk Hastanesi, Çocuk Romatoloji Uzmanı, 2018

Ümraniye Eğitim ve Araştırma Hastanesi, Çocuk Sağlığı ve Hastalıkları-Çocuk Romatoloji Kliniği, 2018-2021

Acıbadem Sağlık Grubu, Çocuk Sağlığı ve Hastalıkları, Çocuk Romatoloji Uzmanı, 2021-Halen

Çocuk Romatoloji Derneği

Avrupa Çocuk Romatoloji Birliği (PReS)

Türk Pediatri Derneği

Milli Pediatri Derneği

Türk Tabipler Birliği

A1. Sağ E, Demir F, Saygın İ, Kalyoncu M, Çakır M. Endoscopic Findings of Children with Familial Mediterranean Fever. Pediatr Gastroenterol Hepatol Nutr. 2018 Oct;21(4):271-277. Doi:10.5223/pghn.2018.21.4.271.

A2. Demir F, Çebi AH, Kalyoncu M. Evaluation of plasma microRNA expressions in patients with juvenile idiopathic arthritis. Clin Rheumatol. 2018 Aug 31. doi:10.1007/s10067-018-4277-x.

A3. Sag E, Demir F, Ercin ME, Kalyoncu M, Cakir M. Neonatal ulcerative colitis associated with Familial Mediterranean fever: a casereport. Rheumatol Int. 2018;38(1):137-140. doi: 10.1007/s00296-017-3848-5.

A4. Cetinkaya M, Cekmez F, Buyukkale G, Erener-Ercan T, Demir F, Tunc T, Aydın FN, Aydemir G. Lower vitamin D levels are associated with increased risk of early-onset neonatal sepsis in term infants. J Perinatol. 2015;35(1):39-45. doi: 10.1038/jp.2014.146.

A5. Tanatar A, Sönmez HE, Karadağ ŞG, Çakmak F, Çakan M, Demir F, Sözeri B, Ayaz NA. Performance of Tel-Hashomer, Livneh, pediatric and new Eurofever/PRINTO classification criteria for familial Mediterranean fever in a referral center. RheumatolInt. 2019 Oct 23. doi: 10.1007/s00296-019-04463-w.

A6. Sozeri B, Ercan G, Dogan OA, Yıldız J, Demir F, Doğanay L. The same mutation in a family with adenosin edeaminase 2 deficiency. Rheumatol Int. 2019 Sep 20. doi: 10.1007/s00296-019-04444-z.

A7. Demir F, Bahadir A, Mungan S, Çobanoğlu Ü, Kalyoncu M. Systemic Amyloidosis in a Patient With Familia lMediterranean Fever and Hodgkin Lymphoma: A Case Report. J Pediatr Hematol Oncol. 2020;42(3):234‐237.

A8. Karadağ ŞG, Sönmez HE, Demir F, et al. Rheumatic diseases in Syrian refugee children: a retrospective multicentric study in Turkey. Rheumatol Int. 2020;40(4):583‐589.

A9. Demir F, Tüzüner T, Baygin Ö, Kalyoncu M. Evaluation of Dental Status and Temporomandibular Joint in Children With Generalized Joint Hypermobility [published online ahead of print, 2020 Mar 5]. J ClinRheumatol. 2020;10.1097/RHU.0000000000001356. doi:10.1097/RHU.0000000000001356

A10. Demır Ferhat, Çebı Alper Han, Kalyoncu Mukaddes (2020). Assessment of Circulating Microribonucleic Acids in Patients With Familial Mediterranean Fever. Archives of Rheumatology, 35(1), 52-59., Doi: 10.5606/ArchRheumatol.2020.7414

A11. Demır Ferhat,Akgün Dogan Özlem,Kendir Demirkol Yasemin,Karadag Serife Gül,et al (2020). Genetic panel screening in patients with clinically unclassified systemic autoinflammatory diseases. CLINICAL RHEUMATOLOGY, Doi: 10.1007/s10067-020-05108-1

A12. Sözerı Betül,Demır Ferhat (2020). A striking treatment option for recalcitrant calcinosis in juvenile dermatomyosistis: tofatinibe citrate. RHEUMATOLOGY, Doi:1 0 . 1 0 9 3 / r h e u m a t o l o g y / k e a a 3 6 0

A13. ÇEBI ALPER HAN,DEMIR FERHAT,Ikbal Mevlit,KALYONCU MUKADDES (2020). Plasma microRNA levels in childhood IgA vasculitis. CLINICAL RHEUMATOLOGY, Doi: 10.1007/s10067-020-05441-5

A14. K Akca Ü, Batu ED, Kısaarslan AP, Poyrazoğlu H, Ayaz NA, Sözeri B, Sağ E, Atalay E, Demir S, Karadağ ŞG, Demir F, Bilginer Y, Gümrük F, Özen S. Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study. Lupus. 2021 May 6:9612033211014271. doi: 10.1177/09612033211014271.

A15. Çakmak F, Çakan M, Demir F, Sonmez HE, Çakmak S, Demirkan FG, Karadağ ŞG, Ayaz NA, Sözeri B. Hepatitis B vaccination response of treatment-naive patients with juvenile idiopathic arthritis. Rheumatol Int. 2021 Mar 18. doi: 10.1007/s00296-021-04833-3.

A16. Sozeri B, Emine Sonmez H, Demir F, Cakan M, Ozturk K, Ozdel S, et al Time to collaborate: Objectives, design, and methodology of PeRA-Research Group. North Clin Istanb. 2021 Feb 25;8(2):200-202. doi: 10.14744/nci.2020.25826.

A17. Sönmez HE, Demir F, Özdel S, Karadağ ŞG, Bağlan E, Bülbül M, et al. Neuroimaging of Children With Takayasu Arteritis. J Child Neurol. 2021 Feb 16:883073821991287. doi: 10.1177/0883073821991287.

A18. Sözeri B, Kardeş E, Salı E, Çakır D, Demir F. Drug survival of the infliximab biosimilar (CT-P13) in paediatric patients with non-infectious uveitis. Clin Exp Rheumatol. 2021 Feb 9.

A19. Kavrul Kayaalp G, Sozeri B, Sönmez HE, Demir F, Cakan M, et al:PeRA-Research Group. Adherence to best practice consensus guidelines for familial Mediterranean fever: a modified Delphi study among paediatric rheumatologists in Turkey. Rheumatol Int. 2021 Jan 16:1–8. doi: 10.1007/s00296-020-04776-1.

A20:          Demir F, Ulu K, Çağlayan Ş, Coşkuner T, Sözeri B. Clinical course of COVID-19 in children with rheumatic disease under biologic therapy. Clin Exp Rheumatol. 2021 Jan-Feb;39

A21:          Batu ED, Kaya Akca U, Pac Kısaarslan A, Sağ E, Demir F, Demir S, et al. The Performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 Classification Criteria in Pediatric Systemic Lupus Erythematosus. J Rheumatol. 2020 Nov 15:jrheum.200871. doi: 10.3899/jrheum.200871.

A22:          Sözeri B, Demir F, Sönmez HE, Karadağ ŞG, Demirkol YK, et al. Comparison of the clinical diagnostic criteria and the results of the next-generation sequence gene panel in patients with monogenic systemic autoinflammatory diseases. Clin Rheumatol. 2021 Jun;40(6):2327-2337. doi: 10.1007/s10067-020-05492-8.

A23. Sözeri B, Çağlayan Ş, Atasayan V, Ulu K, Coşkuner T, Pelin Akbay Ö, ……, Demir F. The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center. Postgrad Med. 2021 Oct 4. doi: 10.1080/00325481.2021.1987732.

A24. Sozeri B, Ulu K, Kaya-Akça U, Haslak F, …., Demir F, Yuksel S, Kalyoncu M, Kasapcopur O, Ozen S, Aktay-Ayaz N. The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study. Rheumatol Int. 2021 Sep 27:1–7. doi: 10.1007/s00296-021-05008-w.

A25. Otar Yener G, Paç Kısaarslan A, Ulu K, …, Demir F, Barut K, Çiftel M, Gürses D, Baykan A, Özsürekçi Y, Karagöz T, Sönmez HE, Bilginer Y, Aktay Ayaz N, Aydoğ Ö, Yüksel S, Sözeri B, Kasapçopur Ö, Özen S. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study. Rheumatol Int. 2021 Sep 7:1–11. doi: 10.1007/s00296-021-04980-7.

A26. Sözeri B, Sönmez HE, Karadağ ŞG, Bağlan E, Öztürk K, Çakan M, Demir F, et al. The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients. Clin Exp Rheumatol. 2021 Sep-Oct;39 Suppl 132(5):118-123

A27. Kalin S, Ciraci S, Cakir D, Oysu AS, Sozeri B, Demir F, Bukte Y. Evaluation of radiological findings in pediatric patients with COVID-19 in Turkey. North Clin Istanb. 2021;8:332-339.

A28. Demirkan F, Ulu K, Öztürk K, Karadağ ŞG, Özdel S, Sönmez HE, Çakmak F, Demir F, Sözeri B, Aktay Ayaz N. Towards the integration of biosimilars into pediatric rheumatology: Adalimumab ABP 501 experience of PeRA research group. Expert Opin Biol Ther. 2021 Nov 3. doi: 10.1080/14712598.2021.2002296.

A29. Ozturk K, Caglayan S, Tanatar A, Baglan E, Yener Otar G, Kavrul Kayaalp G, Karadag SG, Demir F, Sonmez HE, Ozdel S, Cakan M, Aktay Ayaz N, Sozeri B; PeRA-Research Group. Low disease activity state in juvenile-onset systemic lupus erythematosus. Lupus. 2021 Nov 1:9612033211054399. doi: 10.1177/09612033211054399.

A30.  Sag E, Demir F, Sag S, Guven B, Kalyoncu M, Cakir M. Prevalence of celiac disease in children with joint hypermobility. Acta Reumatol Port. 2021 Apr-Jun;46(2):134-139.

A31. Demir F, Sönmez HE, Bağlan E, Akgün Ö, Coşkuner T, Otar Yener G, Öztürk K, Çakan M, Karadağ ŞG, Özdel S, Aktay Ayaz N, Sözeri B. Cluster Analysis of Pediatric Behçet’s Disease: Data from The Pediatric Rheumatology Academy (PeRA)-Research Group (RG). Mod Rheumatol. 2022 May 10:roac044. doi: 10.1093/mr/roac044.

A32. Çakmak F, Demir F, Çakan M, Sonmez HE, Çağlayan Ş, Karadağ ŞG, Varlı YZ, Otar Yener G, Öztürk K, Sözeri B, Aktay Ayaz N. Is it all about age? Clinical characteristics of Kawasaki disease in the extremely young: PeRA research group experience. Postgrad Med. 2022 May;134(4):429-434.